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Introduction
Di abetic neuropathies (DNs) are heterogeneous in their clinical expression and localization. 1, 2 The most common forms are autonomic neuropathy and distal symmetrical polyneuropathy (DSPN) the latter being the most diagnosed in patients with diabetes mellitus (DM). 1, [3] [4] [5] Its prevalence fluctuates between 8 and 40% according to the clinical criteria or laboratory tests used for its diagnosis. [3] [4] [5] [6] Most DM patients with DSPN are asymptomatic 3, 7 and are symptomatic only in 15% of type 1 and 4-13% of type 2 (T2DM) patients. 6, 8, 9 Early diagnosis and treatment are of great importance because (1) DSPN is the chief risk factor for trophic lesions and lower limb amputations in DM patients, 6, 8, 10, 11 and around 85-96% of patients with DSPN are asymptomatic; (2) on occasion, neuropathies due to other aetiologies occur, requiring differential diagnosis; and (3) treatment at an earlier stage should improve prognosis. 12 Neuropathy is usually suspected when subjective symptoms such as burning pain, paraesthesia, hyperesthesia and painful cramps preferentially involving the lower limbs are referred to by aware patients and/or when decreased vibratory (128 Hz tuning fork) and tactile sensation (10g monofilament) and/or derangements of thermal perception and an absent Achilles reflex are observed. In symptomatic patients (only 4-15% of DM patients with neuropathy), these methods allow clinical diagnosis of DSPN in 87% of the cases. 13 In asymptomatic individuals with DSPN, the limitations of these methods may under diagnose 85-96% of these patients. To palliate this limitation and improve diagnostic sensitivity, electromyography (EMG) and nervous conduction (NC) are the most used techniques to quantitate peripheral large myelinated fiber function in symptomatic and asymptomatic DM patients, 14, 15 but EMG/NC are bothersome and techniques using electric currents to measure NC and needles to study muscle innervation are uncomfortable. These techniques do not evaluate small fiber, which conduct autonomic function, sense cold, heat, and pain, and are altered earlier than thick fiber in DM patients and glucose intolerants. 15, [16] [17] [18] [19] [20] Hence our interest in comparing DSPN frequency in T2DM patients by using two different methods: (1) thermal threshold (TT) which studies small fiber function and (2) EMG and NC, which study large fiber function.
Patients and Methods
Because it is impossible to determine how many years of subclinical evolution the disease already has, and in order to improve the reliability of the TT technique, avoid distortion, and mark a difference regarding other reports and reviews, 21 an extremely select sample of 70 T2DM patients were chosen (39 men, 31 women) using the following criteria: no central nervous system damage, normal IQ, homogeneous educational level, no cognitive derangement (Wais Test), normal consciousness, and no psychiatric condition (Minnesota MultiPhasic Personality Inventory and Rorschach Test). In addition, other causes of peripheral neuropathy were ruled out using vitamin B12 and folic acid levels, thyroid hormones, electrolytes, calcium, phosphorus, magnesium, plasma protein and immunoglobulin electrophoresis, liver tests, chest x-rays, abdomen ultrasound, and gynecological evaluations.
All patients have T2DM and are clinically asymptomatic for small and large fiber neuropathy. They present no alteration in reflexes, sensitivity, or muscle strength. Diabetic neuropathy is their only evident complication. All other complications were discarded.
The patients had a clinic evolution time from 1 to 48 months since the date of diagnosis of diabetes. Their average age was 54 ± 10, ranging from 32 to 78 years old.
We considered the date of diagnosis as the day in which the diagnosis was confirmed with conclusive laboratory tests according to criteria of the American Diabetes Association or World Health Organization. 22, 23 Of the 39 men, 18 were medically checked once a year, making it very probable that their T2DM was diagnosed at an early stage of the disease.
All patients were being treated with oral hypoglycemic medication and had negative metabolic control levels with hemoglobin A1c greater than 7% and less than 8%.
All were submitted to a neurological clinical examination, distal and bilateral TT and NC studies (NC velocity and measurements of latencies and amplitudes of sensory and motor potentials).
The NC test was performed with a Nicolet Viking IV ® (Nicolet Biomedical, Memphis, TN) electromyography system. The parameters studied were: motor conduction velocity, latency and amplitude of the distal motor potential in the median and peroneal nerves, sensory conduction velocity of the median nerve in the wrists and forearms, and conduction latency and amplitude of the distal sensory potential in the median, ulnar, and sural nerves on both sides.
For NC studies, criteria considered as diagnostic of DSPN were: (A) bilateral and symmetrically reduced sensory or sensorimotor conduction velocities in the lower limbs or in the upper and lower limbs simultaneously; (B) bilateral and symmetrically reduced sensory or motor amplitudes in the lower or in the upper and lower limbs simultaneously; or (C) concomitance of (A) and (B). Table 1 shows normal values using similar criteria to those in literature. 24 The TT study was performed with a computerized Nicolet Sensation ® (Israel) equipment according to the technique described in Marstock 25 in which the temperature changes are issued through a contact probe (surface 3 × 4 cm) attached to the patient's skin. The velocity of the rise or falls of the probe's temperature as well as its basal temperature are pre-established and computerized. Standardization of the TT was achieved according to international standards 25, 26 as was the evaluation of 80 healthy volunteers without evidence of intellectual derangement (Wais test) and/or neuropathy. Each center should establish its own normality criteria because parameters such as basal skin temperature, stimulation site, age, race and others can influence them. 27 In order to avoid the possibility of malingering, the test was performed twice on separate occasions in each patient.
The TT parameters studied were: (1) sensory thresholds to cold and heat and (2) pain thresholds induced by cold and heat on both palms and on the dorsum and soles of both feet.
Thermal threshold criteria considered for the diagnosis of small fiber distal and symmetrical DN were: (1) when the standardized reference value for each of these thresholds from our laboratory were surpassed in more than two standard deviations (SDs) bilaterally and symmetrically in lower limbs or in lower and upper limbs simultaneously and/or (2) when hyperalgesia to heat or cold or paradoxical reactions to heat or cold appeared bilaterally and symmetrically. (See Table 2 
.)
We used the latest update of expert panels (Toronto, Canada 2009) classification. This new classification defines minimal criteria for typical diabetic polyneuropathy in possible, probable, confirmed, and subclinical distal DN. According to this classification, 28 we classified our results of NC in (A) normal without DSPN, and (B) abnormal with subclinical DSPN, corresponding to subclinical DSPN. 28 The results applying the TT allowed the classification of patients into two groups: (A) normal and (B) altered: with small fiber dysfunction [subclinical small fiber neuropathy (SFN)].
All our patients were 100% asymptomatic. Expressions of SFN damage were evident only as a result of the application of TT. This technique is presumably vouched for by the experts panel in Toronto 28 that suggest the use of a quantitative methodology as abnormal quantitative sensory testing TTs of the foot and/or skin biopsy and intraepidermal nerve fiber density at the ankle. All patients provided informed signed consent and the Ethics Committee of our hospital approved the protocol.
Results
In the NC test, 57 patients were normal (81% of the sample) and only 13 were diagnosed with distal and symmetric large fiber DN (19%). In 2 cases we found a sensorimotor neuropathy (alterations in the motor amplitude of the peroneal nerve and sensory amplitude of the sural nerve), in 11 cases we found only a sensory neuropathy (alterations in the sensory amplitude of the sural nerve). No case with alterations in the upper limbs.
In the TT study, 30 patients were diagnosed with distal and symmetric SFN (43%) whereas the remaining 40 patients (57%) were normal (Table 3 ). In the 30 cases, alterations of the TT were found in the dorsum and soles of the feet. There were no patients with abnormalities in the upper limbs.
The frequency of SFN studied with the TT test is significantly greater (p < 0.001) than the frequency of large fiber neuropathy studied with the NC test (Table 3) .
Regarding age, the T2DM patients with a normal NC averaged 52 years compared to those with altered NC, who averaged 61 years (p < 0.001).
There were no significant differences between these two groups regarding time of clinical evolution since the date of diagnosis of diabetes (Table 3) .
The group with the altered TT had an average age of 56 years and those with a normal TT had an average of 52 years (statistically not significant). The time elapsed since the date of diagnosis did not show significant differences between these two groups ( Table 3) .
The subgroup of patients with an altered TT but with normal NC was in average 9 years younger than the group of patients with both altered TT and NC (52 versus 61 years, statistically significant, p < 0.005).
There was no significant difference between the groups regarding time of evolution since the date of diagnosis of diabetes (Table 3) .
Forty patients had a normal TT (57%) and none of them showed derangements in NC. Thirty patients were found to have an altered TT (43%) and 17 of these had normal NC ( Table 4 ).
If a bilaterally and symmetrically altered TT was always an expression of DN, then the 17 cases found in this group with an altered TT and normal NC should be considered as "false negative of the NC for DN," CI 95% (45-69%) ( Table 4 ).
If the capability of the TT test to detect true bearers of DN was 100%, it would be only 43% for NC (13 altered NC/30 altered TT), CI 95% (26-61%).
The probability that a patient with a normal NC has no neuropathy (40 true negatives/57 cases with a normal NC) in the sample is 70%, CI 95% (58-82%), thus implying that, if the NC is normal, then there is a 30% probability of having neuropathy.
Regarding the small fiber, the most common alterations found in measured parameters are shown in Table 5 .
The number of altered parameters of TT is directly correlated to age (p < 0.05) and not to the time of evolution of diabetes since the date of diagnosis (p > 0.10) ( Table 6) .
Normal values found in 80 volunteers in repeated TT (first and second tests) are shown in Table 7 .
Discussion
In other reports, 21 we found that the groups of patients and the methods used were not comparable to each other. We feel that a single computerized methodology of TT should be used in order to minimize the theoretical limitations of the different techniques (computerized or not) evaluated in the American Neurological Association 21 report, where different kinds of patients as well as different times of clinical and subclinical evolution of the disease were mixed. The same is supported by other authors who value the use of the TT test in diagnosis of DN prior to large fiber damage. [30] [31] [32] [33] The results of our research show a 19% frequency of distal large fiber sensory or sensorimotor neuropathy when the NC technique was applied and 43% of SFN when the TT technique was used (p < 0.001). Both types of damage would be the expression of distal and symmetric DN in different stages of the disease. 34 If Table 1 is analyzed, it can be seen that small fiber alterations appear at earlier ages and that large fiber damage appears later. Even though it can be affirmed that age itself plays a permissive role in the expression of the type of damaged fiber, probably, the compromise is more related to a longer time of evolution of T2DM in the subclinical stage. 3, 5, 35 Although ample information supports the influence of the time of evolution and metabolic control of the disease on fiber damage, 3, 5, 36, 37 our study design (patients of up to 4 years of evolution since the date of diagnosis) does not allow us to demonstrate the relationship between neuropathy and the actual clinical and subclinical evolution.
Studies using skin biopsies describing SFN in DM and glucose intolerant patients [17] [18] [19] 38, 39 support the fact that small fiber damage, also distal and symmetrical, precedes large fiber damage found with the NC test.
An explanation for early damage of small fiber is based upon a greater vulnerability of these to the metabolic damage of oxidative and vascular stress in the axon and endoneurium induced by glyco and lipotoxicity, which will finally lead to axonal degeneration and atrophy. 36, 40, 41 Puncture skin biopsy and intraepidermal nerve fiber density count should be the reference standard 28 in indicating structural small fiber damage, but it is an invasive, complex, and expensive technique [25] [26] [27] [28] that is difficult to apply on a great scale. Thus, less invasive and cheaper techniques to study small fiber function should be considered, among which the TT technique could be a reasonable choice. 30 Further research must be carried out to compare both techniques.
Our results show the following: (1) of all our patients with confirmed DN, 57% have only distal and symmetric small fiber damage demonstrated with the TT method; (2) an altered NC always has an altered TT; (3) a normal TT always has a normal NC; and (4) a higher number of altered parameters exist in TT with higher age.
Based on bibliographic evidence that show that (1) alterations in small fiber (A delta and C) found with the TT test have a progressive and evolving character confirmed by skin biopsy and intraepidermal fiber count [30] [31] [32] [33] [34] and (2) small and not large fiber damage exists in glucose intolerants, [17] [18] [19] we propose that in the study of subclinical DN (having discarded other causes of neuropathy) TT can be a more useful technique than NC because it would allow the diagnosis of small fiber damage that may precede large fiber damage, allowing earlier diagnosis especially in clinically asymptomatic patients.
We support the efforts 28 to review the clinical and laboratory criteria used 13, 42 for diagnosis of DN. The place given to TT as a technique for diagnosis of small fiber damage in asymptomatic and symptomatic patients remains to be determined. Hence the existence of literature that supports this methodology, and supports the belief that small fiber damage precedes large fiber damage. [30] [31] [32] [33] [34] We recommend the TT test for diagnosis of diabetic SFN in asymptomatic, cooperative and lucid patients, with slight or no cognitive derangement and in every newly diagnosed T2DM patient, including those in which EMG/ NC are normal.
